Quarterly Report · 10-Q
Thermo Fisher Scientific, Inc. TMO NYSE EQUITY Current
Add to THEMA watchlist → Follow this company’s filings → Quarterly Report Filed Oct 30, 2026 Accepted Oct 30, 2026, 10:52 AM EDT CIK 97745 Accession 0000097745-26-000179
Company context Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Current securities Registered securities in this filing THERMO FISHER SCIENTIFIC INC. · 10-Q · Filed 2026-10-30
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, $1.00 par value
Exchange NYSE
Classification COMMON
Status Current Filing context Context: c-2
Dimensions: us-gaap:StatementClassOfStockAxis
1.450% Notes due 2027
Symbol TMO 27
Exchange NYSE
Classification DEBT Filing context Context: c-3
Dimensions: us-gaap:StatementClassOfStockAxis
1.750% Notes due 2027
Symbol TMO 27B
Exchange NYSE
Classification DEBT Filing context Context: c-4
Dimensions: us-gaap:StatementClassOfStockAxis
Floating Rate Notes due 2027
Symbol TMO 27D
Exchange NYSE
Classification DEBT Filing context Context: c-5
Dimensions: us-gaap:StatementClassOfStockAxis
0.500% Notes due 2028
Symbol TMO 28A
Exchange NYSE
Classification DEBT Filing context Context: c-6
Dimensions: us-gaap:StatementClassOfStockAxis
1.375% Notes due 2028
Symbol TMO 28
Exchange NYSE
Classification DEBT Filing context Context: c-7
Dimensions: us-gaap:StatementClassOfStockAxis
1.950% Notes due 2029
Symbol TMO 29
Exchange NYSE
Classification DEBT Filing context Context: c-8
Dimensions: us-gaap:StatementClassOfStockAxis
0.875% Notes due 2031
Symbol TMO 31
Exchange NYSE
Classification DEBT Filing context Context: c-9
Dimensions: us-gaap:StatementClassOfStockAxis
2.375% Notes due 2032
Symbol TMO 32
Exchange NYSE
Classification DEBT Filing context Context: c-10
Dimensions: us-gaap:StatementClassOfStockAxis
3.650% Notes due 2034
Symbol TMO 34
Exchange NYSE
Classification DEBT Filing context Context: c-11
Dimensions: us-gaap:StatementClassOfStockAxis
3.628% Notes due 2035
Symbol TMO 35A
Exchange NYSE
Classification DEBT Filing context Context: c-12
Dimensions: us-gaap:StatementClassOfStockAxis
2.875% Notes due 2037
Symbol TMO 37
Exchange NYSE
Classification DEBT Filing context Context: c-13
Dimensions: us-gaap:StatementClassOfStockAxis
1.500% Notes due 2039
Symbol TMO 39
Exchange NYSE
Classification DEBT Filing context Context: c-14
Dimensions: us-gaap:StatementClassOfStockAxis
1.875% Notes due 2049
Symbol TMO 49
Exchange NYSE
Classification DEBT Filing context Context: c-15
Dimensions: us-gaap:StatementClassOfStockAxis
Accession 000009774526000179 · 14 registered-security cover members
Read the exact SEC filing ↗
As-filed source Primary evidence